Recursion Pharmaceuticals Inc. surged as breakthrough AI-driven drug discovery progress fueled bullish sentiment, and stocks ...

Recursion Pharmaceuticals Inc. stocks have been trading up by 15.41 percent amid heightened optimism over its AI-driven drug ...

Recursion’s August business update highlighted that Genentech opted its first neuroscience target into an early discovery ...

Tempus AI Inc. stocks have been trading up by 6.55 percent after bullish coverage on its AI-driven healthcare data platform.

As October begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The ...

- Recursion Pharmaceuticals RXRX+16.63% (RXRX) surges 16.38% on heavy volume, trading near $4.83 intraday high. - Extended 2029 Tempus AI TEM +8.11% partnership replaces $84M potential fees with $42M ...

Five stocks stand out for elevated short positioning in the latest mid- to mega-cap screen, with bearish bets exceeding 30% of shares outstanding at each of the top five names. Strive (NASDAQ:ASST) ...

According to MarketsandMarkets™, the AI in Protein Engineering Market is projected to reach USD 3.82 billion by 2031 from USD 1.44 billion ...

Build.In recent years, Slalom has focused its business on "Leading with AI." For us, "Leading with AI" is not just a slogan ...

Arize AI's Laurie Voss makes the case that human developers are now the bottleneck in improving AI agents. In a live walkthrough building a ...

Every few years, the programming world converges on a handful of languages and treats them as the only serious options. JavaScript, Python, Java, C, and now Rust and Go dominate job listings, ...